What type of control status does Soma fall under?

Soma, known generically as carisoprodol, is classified as a controlled substance, specifically under the C-4 schedule. This classification indicates that it has a recognized medical use but also carries a risk of abuse and dependence, although the potential for these issues is lower than substances classified as C-3 or C-2.

Schedule C-4 drugs are intended for medical use while also being regulated to prevent misuse. Carisoprodol is commonly prescribed for muscle spasms and related conditions, but due to its sedative effects and potential for addiction, it is meticulously controlled. This regulation helps ensure that its benefits in a therapeutic context are balanced against the risks of misuse.

In contrast, options characterized as no control or C-3 would indicate fewer restrictions, which is not applicable in the case of Soma, given its recognized risks. C-5 substances are considered to have an even lower potential for abuse compared to C-4 substances, making them less relevant to carisoprodol's classification.